No Oral Sites (ICD-10) Control group Precancerous Cancerous Grand Total
Leukoplakia Erythroplakia Benign Malignant
Male Female Male Female Male Female Male Female Male Female
1 Lip 5(6.1) 6(11.1) 2(13.3) 2(14.3) 1(5.9) 2(22.2) 2(5.7) 1(5.0) Nil 1(9.1) 22(8.8)
2 Tongue 11(13.4) 7 (12.97) 4(26.7) 2(14.3) 3(17.6) 1(11.1) 2(5.7) 2(10.0) 2(13.3) 2(18.2) 36(13.2)
3 Alveolus and gingiva 16(19.5) 6(11.1) 3(20.0) 2(14.3) 2(11.8) 2(22.2) 8(22.9) 1(5.0) 3(20.0) 1(9.1) 44(17.6)
4 Floor of the mouth 7(8.5) 6(11.1) 2(13.3) 3(21.4) 1(5.9) 1(11.1) 3(8.60) 2(10.0) 1(6.7) Nil 26(9.5)
5 Palate 6(7.3) 3(5.6) Nil Nil 3(17.6) 1(11.1) 2(5.7) 2(10.0) 1(6.7) Nil 18(6.5)
6 Buccal mucosa 37(45.2) 26(48.2) 4(26.7) 5(35.7) 7(41.2) 2(22.2) 18(51.4) 12(60.0) 8(53.3) 7(63.6) 126(46.4)
Total 82 54 15 14 17 09 35 20 15 11 272
Table 1: Degree of pathogenicity, oral site and sex-wise collected samples.